{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:28:20Z","timestamp":1785583700504,"version":"3.56.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Toxic epidermal necrolysis (TEN) is a life-threatening severe cutaneous adverse drug reaction with high mortality. Acute kidney injury (AKI) is a common complication of TEN, significantly increasing mortality risk. Immunocompromised patients frequently require combination therapy with voriconazole and co-trimoxazole for concurrent infections, which may lead to complex toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>\n                      A 60-year-old male with nephrotic syndrome on long-term corticosteroids was diagnosed with\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      and\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      co-infection. He was initiated on voriconazole and co-trimoxazole on Day 6 and discharged on Day 9. Following a 20-day interruption of co-trimoxazole, he resumed the drug on Day 37 and developed widespread mucocutaneous erythema within hours. He presented on Day 40 with stage 2 AKI (eGFR 39\u00a0mL\/min\/1.73\u00a0m\n                      <jats:sup>2<\/jats:sup>\n                      ) and severe systemic inflammation. Upon admission on Day 42, TEN was diagnosed with skin detachment &amp;gt;30% body surface area. Trough voriconazole level was 9.81\u00a0mg\/L (therapeutic upper limit 5.5\u00a0mg\/L). Pharmacogenetic testing revealed CYP2C19 *1\/*2 genotype (intermediate metabolizer). ALDEN score was 9 for co-trimoxazole (\u201chighly probable\u201d) and 4 for voriconazole (\u201cprobable\u201d). Renal replacement therapy was initiated on Day 49. Despite comprehensive treatment and transient improvement of skin lesions, the patient ultimately died on Day 63, 17 days after the initiation of hemodialysis. The precise cause of death could not be determined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Co-trimoxazole rechallenge strongly supports a causal link to TEN. AKI pathogenesis was multifactorial: primarily driven by TEN-associated systemic inflammation, with voriconazole accumulation due to CYP2C19 intermediate metabolism and drug interaction serving as a likely exacerbating co-factor. This case underscores the importance of therapeutic drug monitoring, pharmacogenetic testing, and integrated cross-organ surveillance when using high-risk antimicrobial combinations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/ftox.2026.1797771","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:18:12Z","timestamp":1782094692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxic epidermal necrolysis and acute kidney injury following co-trimoxazole rechallenge and voriconazole accumulation as an exacerbating cofactor: a case report"],"prefix":"10.3389","volume":"8","author":[{"given":"Yu-Dong","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Union Hospital Tongji Medical College Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]},{"name":"Department of Pharmacy, Yellow River Sanmenxia Hospital","place":["Sanmenxia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Lan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital Tongji Medical College Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital Tongji Medical College Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital Tongji Medical College Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jing","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital Tongji Medical College Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40264-019-00825-2","article-title":"Mechanisms of severe cutaneous adverse reactions: recent advances","volume":"42","author":"Bell\u00f3n","year":"2019","journal-title":"Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijantimicag.2014.05.019","article-title":"Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity","volume":"44","author":"Dolton","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1592\/phco.21.15.1233.33901","article-title":"Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin","volume":"21","author":"Hsu","year":"2001","journal-title":"Pharmacotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000195632","article-title":"Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"29","author":"Hung","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit. Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e13887","DOI":"10.1111\/cts.13887","article-title":"Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole","volume":"17","author":"Klomp","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bcp.70501","article-title":"Inflammation-driven variability in drug metabolism: insights from voriconazole treatment of HSCT recipients","author":"Klomp","year":"2026","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0203642","DOI":"10.1371\/journal.pone.0203642","article-title":"The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: the prognostic value of KDIGO staging","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jaip.2025.08.001","article-title":"HLA-B alleles with shared peptide binding specificities define global risk of co-trimoxazole-induced severe cutaneous adverse drug reactions","volume":"13","author":"Li","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/PGPM.S329662","article-title":"Analysis of combined effect of CYP2C19 genetic polymorphism and proton pump inhibitors coadministration on trough concentration of voriconazole","volume":"14","author":"Mafuru","year":"2021","journal-title":"Pharmgenomics Pers. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.clpt.2006.04.004","article-title":"Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir","volume":"80","author":"Mikus","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.dmpk.2022.100480","article-title":"Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions","volume":"47","author":"Nakkam","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000441280","article-title":"Drug hypersensitivity: how drugs stimulate T cells via pharmacological interaction with immune receptors","volume":"168","author":"Pichler","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"939210","DOI":"10.3389\/fmed.2022.939210","article-title":"Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients","volume":"9","author":"Rattanakaemakorn","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","article-title":"Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1681\/ASN.2006050418","article-title":"Involvement of drug-specific T cells in acute drug-induced interstitial nephritis","volume":"17","author":"Spanou","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.clinthera.2022.10.005","article-title":"Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-asian and Asian adult patients: consensus review by the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring","volume":"44","author":"Takesue","year":"2022","journal-title":"Clin. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"107524","DOI":"10.1016\/j.ijantimicag.2025.107524","article-title":"Association of antibiotics with Stevens-Johnson syndrome and toxic epidermal necrolysis: a real-world pharmacovigilance study","volume":"66","author":"Yan","year":"2025","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1797771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:18:13Z","timestamp":1782094693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1797771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":19,"alternative-id":["10.3389\/ftox.2026.1797771"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2026.1797771","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1797771"}}